Spyre Therapeutics expects six trial readouts in 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. DVLT
8. ADYYF
9. WDAY
10. ADYEN:NA

Go back to Spyre Therapeutics expects six trial readouts in 2026
(NASDAQ: SYRE) Delayed: 103.63 +1.78 (1.75%)
Previous Close $101.85    52 Week High $ 
Open $101.21    52 Week Low $ 
Day High $104.13    P/E N/A 
Day Low $95.61    EPS $ 
Volume 559,505